Multiple Assemblies exist for SMTL entry 1z5l
Structure of a highly potent short-chain galactosyl ceramide agonist bound to CD1D; X-RAY DIFFRACTION 2.20 Å

	SMTL ID 1z5l.1 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; 2-acetamido-2-deoxy-beta-D-glucopyranose; (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL; HEXADECANE Polypeptides T-cell surface glycoprotein CD1d antigen; Beta-2-microglobulin Oligo-state hetero-1-1-mer
	SMTL ID 1z5l.2 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; 2-acetamido-2-deoxy-beta-D-glucopyranose; (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL; HEXADECANE Polypeptides T-cell surface glycoprotein CD1d antigen; Beta-2-microglobulin Oligo-state hetero-1-1-mer
	SMTL ID 1z5l.3 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; 2-acetamido-2-deoxy-beta-D-glucopyranose; (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL; HEXADECANE Polypeptides T-cell surface glycoprotein CD1d antigen; Beta-2-microglobulin Oligo-state hetero-2-2-mer